Format

Send to

Choose Destination
Trends Mol Med. 2002 Oct;8(10):476-82.

Hepatitis C: molecular virology and antiviral targets.

Author information

1
Department of Medicine II, University of Freiburg, Hugstetter Strasse 55, Germany. Darius.Moradpour@uni-freiburg.de

Abstract

Chronic hepatitis C is a leading cause of liver cirrhosis and hepatocellular carcinoma worldwide. Although current treatment options are limited, progress in understanding the molecular virology of hepatitis C has led to the identification of novel antiviral targets. Moreover, in vitro and in vivo model systems have been developed that allow systematic evaluation of new therapeutic strategies. This review details current concepts in molecular virology and emerging therapies for hepatitis C.

PMID:
12383770
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center